1. Home
  2. LXFR vs EBS Comparison

LXFR vs EBS Comparison

Compare LXFR & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Luxfer Holdings PLC

LXFR

Luxfer Holdings PLC

HOLD

Current Price

$12.19

Market Cap

421.4M

Sector

Industrials

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$7.88

Market Cap

409.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXFR
EBS
Founded
1898
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
421.4M
409.5M
IPO Year
2002
2006

Fundamental Metrics

Financial Performance
Metric
LXFR
EBS
Price
$12.19
$7.88
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
230.8K
716.6K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
4.26%
N/A
EPS Growth
N/A
125.83
EPS
0.28
0.93
Revenue
$384,600,000.00
$742,900,000.00
Revenue This Year
N/A
$1.29
Revenue Next Year
$5.01
N/A
P/E Ratio
$43.61
$8.71
Revenue Growth
N/A
N/A
52 Week Low
$9.41
$4.02
52 Week High
$16.03
$14.06

Technical Indicators

Market Signals
Indicator
LXFR
EBS
Relative Strength Index (RSI) 43.92 34.58
Support Level $11.32 $7.51
Resistance Level $12.71 $9.28
Average True Range (ATR) 0.43 0.28
MACD 0.12 0.10
Stochastic Oscillator 55.21 6.88

Price Performance

Historical Comparison
LXFR
EBS

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: